Mediproxi SRL

Mediproxi reported total assets of 194,055 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026).

Company number (CBE) 1009.924.111 · VAT BE1009924111
1060 Saint-Gilles
active in General medical practice activities (NACE 86210)
operating since 31 May 2024 (≈ 2 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Mediproxi shows with a free account.

See the score
Profile
SRL since 2024
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result79,707 €
Equity146,931 €
Cash159,898 €
EBITDA147,313 €
Total assets194,055 €
Solvency75.7%
The line marks its sector median: 69.3% (944 companies).

Accounts of the company itself (not consolidated).

The full file covers 2 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Mediproxi's annual accounts

20252024
Net result79,707 €
Equity146,931 €
Cash159,898 €
EBITDA147,313 €
Total assets194,055 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 24 Jul 2026
  • Year ended 31 Dec 2024filed on 24 Jul 2025

Mediproxi's financial analysis

Management and control of Mediproxi

1 active director(s) in the register.

Mediproxi's shareholders and holdings →

Mediproxi's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
1009.924.111
VAT number
BE1009924111
Peppol
Registered · 0208:1009924111 · as of 10 Nov 2026
Legal form
SRL
Incorporated
31 May 2024
Registered office
1060 Saint-Gilles
Latest accounts
2025 · filed on 24 Jul 2026
Activity
General medical practice activities (NACE 86210)

Mediproxi (SRL) has been based in Saint-Gilles since 2024, active in: general medical practice activities. For 2025, it reports a net profit of 79,707 € and equity of 146,931 €; its revenue is not published. Its solvency stands at 75.7%, above the median of its sector (69.3%).

Companies similar to Mediproxi

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Mediproxi

What is the revenue of Mediproxi?

Mediproxi files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Mediproxi?

In Belgium, the VAT number is the company number prefixed with BE: BE1009924111 for Mediproxi, if the company is VAT-registered. Its company number (CBE) is 1009.924.111.

Where is the registered office of Mediproxi?

According to the CBE register, the registered office of Mediproxi is in 1060 Saint-Gilles.

What is the equity of Mediproxi?

At the close of the 2025 financial year, the equity of Mediproxi amounts to 146,931 €, a solvency of 75.7% of total assets.

Who manages Mediproxi?

The register lists 1 active mandates at Mediproxi. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Mediproxi

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 25 Jul 2026

No credit card, no commitment.

What each plan unlocks →